Through an integrative approach involving protein-protein interactions, GWAS, and transcriptomic analyses, researchers have begun to unravel the complex relationship between FYCO1 expression and disease progression, offering valuable insights into the genetic determinants of COVID-19 severity. Here, FYCO1 is linked to COVID-19.